N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine
C25H30N4O2S2 — CID 155728763
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine
N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine (PubChem CID 155728763) has the molecular formula C25H30N4O2S2 and a molecular weight of 482.68 g/mol. Its IUPAC name is N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine.
Molecular Properties
| Compound Name | N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine |
|---|---|
| PubChem CID | 155728763 |
| Molecular Formula | C25H30N4O2S2 |
| Molecular Weight | 482.68 g/mol |
| Exact Mass | 482.18 |
| IUPAC Name | N-[3-[(Z)-but-2-en-2-yl]sulfanylbut-3-en-2-yl]-6-(5-methyl-1,3-thiazol-2-yl)-8-(oxan-4-yloxy)quinazolin-4-amine |
| SMILES | C=C(S/C(C)=C\C)C(C)Nc1ncnc2c(OC3CCOCC3)cc(-c3ncc(C)s3)cc12 |
| InChI | InChI=1S/C25H30N4O2S2/c1-6-15(2)32-18(5)17(4)29-24-21-11-19(25-26-13-16(3)33-25)12-22(23(21)27-14-28-24)31-20-7-9-30-10-8-20/h6,11-14,17,20H,5,7-10H2,1-4H3,(H,27,28,29)/b15-6- |
| InChIKey | HFTAYXWIRXSTOF-UUASQNMZSA-N |
| XLogP | 6.59 |
| TPSA | 69.16 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.68 |
| LogP ≤ 5 | 6.59 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155728763 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.